Speakers

DeOndra Dixon

Global Down Syndrome Foundation Ambassador;
Quincy Jones Exceptional Advocacy Award Recipient
 
Welcome Address

Frank Stephens

Global Down Syndrome Foundation Ambassador;
Quincy Jones Exceptional Advocacy Award Recipient
 
The Importance of Research for People with Down Syndrome

Joaquín Espinosa, PhD

Executive Director, Linda Crnic Institute for Down Syndrome, Professor in the Department of Pharmacology at the University of Colorado School of Medicine, Co-Leader of the Molecular Oncology program at the University of Colorado Cancer Center, and founding Director of the Functional Genomics Facility at the University of Colorado
 
Immune Modulation in Down syndrome and COVID-19

Ed Janoff, MD

Clinical Professor, Medicine-Infectious Disease, University of Colorado School of Medicine
 
Living Safely with Down Syndrome in the Age of COVID-19

Mike Ybarra, MD, FAAEM, FACEP

Deputy VP of Advocacy & Strategic Alliances, PhRMA
 
The Biopharmaceutical Industry’s Efforts to Beat Coronavirus

Michelle Sie Whitten, MA

President & CEO, Global Down Syndrome Foundation
Executive Director, Anna and John J. Sie Foundation
Crnic Institute for Down Syndrome Board of Directors
 
Our Response to COVID-19 and the “COVID-19 Down Syndrome QA” Collaborative

Karen Gaffney

Quincy Jones Exceptional Advocacy Award Recipient
 
Welcome Address

Kelly Sullivan

Boettcher Investigator, Assistant Professor, Linda Crnic Institute for Down Syndrome, Department of Pediatrics, Section of Developmental Biology, University of Colorado Anschutz Medical Campus
 
Immune System Dysregulation in Down syndrome

Kent McKelvey, MD

Associate Professor in Medical Genetics and Family Medicine, University of Arkansas for Medical Sciences
 
Medical Guidelines For Adults with Down Syndrome

Mike Rafii, MD, PhD

Associate Professor of Clinical Neurology, Keck School of Medicine, University of Southern California; Medical Director of the Alzheimer’s Therapeutic Research Institute and the NIH-funded Alzheimer’s Clinical Trial Consortium; Principal Investigator for the Down Syndrome Biomarker Initiative; Steering Committee Member of the NIH-funded Alzheimer’s Biomarker Consortium
 
Alzheimer’s Disease in Down Syndrome | Latest Updates

Melissa Parisi, MD, PhD

Chief of the Intellectual & Developmental Disabilities Branch, Eunice Kennedy Shriver NICHD National Institutes of Health, DS-Connect Registry Manager
 
Promising Research at the NIH